Indrayani Biotech Ltd

Indrayani Biotech Fund Raise

Indrayani Biotech revised its Rights Issue schedule to June 25 – July 24, 2026. This administrative update adjusts the capital raising timeline for eligible equity shareholders.

Indrayani Biotech Fund Raise

Indrayani Biotech Limited's Rights Issue Committee has approved the Letter of Offer, Abridged Letter of Offer, and Composite Application Form for its proposed rights issue. This marks a key procedural milestone in the company's capital-raising process.

Indrayani Biotech Fund Raise

Indrayani Biotech Ltd has announced the ISIN (INE007C20013) for its upcoming Rights Entitlement. The issue involves partly paid-up equity shares with a face value of Rs.10 and a paid-up value of Rs.2.50 each. This follows the board's approval on April 9, 2026, for raising capital through a rights issue.

Indrayani Biotech Fund Raise of ₹48.79 Cr

Indrayani Biotech Limited has fixed April 28, 2026, as the record date for its ₹48.79 Crore rights issue. Eligible shareholders will receive 5 rights shares for every 7 shares held at an issue price of ₹15 per share.

Value

₹48.79 Cr

Indrayani Biotech Fund Raise of ₹49.9 Cr

Indrayani Biotech Ltd has approved a rights issue of 3,25,25,897 partly paid-up equity shares at ₹15 per share, aggregating upto ₹49.90 Crore. The record date is set for April 28, 2026, with the issue opening on May 27, 2026. The rights entitlement ratio is 5 shares for every 7 shares held.

Value

₹49.90 Cr

Indrayani Biotech Fund Raise

Indrayani Biotech Ltd's Rights Issue Committee will meet on April 9, 2026, to finalize the price, entitlement ratio, and record date for its upcoming partly paid-up Rights Issue. The committee will also appoint a monitoring agency and banker to manage the capital raise process and ensure compliance.